Table 2.
Demographic and disease cCharacteristics for PsO patients
| Variable | Psoriasis group N = 20 |
|---|---|
| Age (years) (mean, SD) | 51.9 (± 10.8) |
| Sex F:M | 9:11 (55% male) |
| BMI (kg/m2) (mean, SD) | 33.7 (± 6.8) |
| PASI (mean, SD) | 3.8 (± 4.2) |
| BSA (mean, SD) | 4.5 (± 4.7) |
| TJC | 3.05 (4.8) |
| Enthesitis (%) | 25% |
| Enthesitis (LEI mean) | 1.5 (2.79) |
| NSAIDs (%) | 35% |
| DMARDs | 10% |
| TNF alpha inhibitors (%) | 0 |
| Corticosteroids (%) | 0 |
| Topical corticosteroids (%) | 75% |
BMI body mass index, PASI Psoriasis Area and Severity Index, BSA body surface area, NSAID non-steroid anti-inflammatory drugs, DMARDs disease-modifying anti-rheumatic drugs, TNF tumor necrosis factor